Evidence map›Paper›PMID 27428020›Full record

ArticlePloS one2016

Gremlin-1 Overexpression in Mouse Lung Reduces Silica-Induced Lymphocyte Recruitment - A Link to Idiopathic Pulmonary Fibrosis through Negative Correlation with CXCL10 Chemokine.

Katri Koli, Eva Sutinen, Mikko Rönty, Pia Rantakari, Vittorio Fortino, Ville Pulkkinen, Dario Greco, Petra Sipilä, Marjukka Myllärniemi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Katri KoliResearch Programs Unit, Translational Cancer Biology, University of Helsinki, Helsinki, Finland.
Eva SutinenTransplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland.
Mikko RöntyDepartment of Pathology, University of Helsinki and Fimlab laboratories, Pathology, Tampere, Finland.
Pia RantakariMediCity Research Laboratory, University of Turku, Turku, Finland.
Vittorio FortinoUnit of Systems Toxicology and Nanosafety Centre, Finnish Institute of Occupational Health (FIOH), Helsinki, Finland.
Ville PulkkinenUniversity of Helsinki and Helsinki University Hospital, Heart and Lung Center, Department of Pulmonary Medicine, Helsinki, Finland.
Dario GrecoUnit of Systems Toxicology and Nanosafety Centre, Finnish Institute of Occupational Health (FIOH), Helsinki, Finland.
Petra SipiläDepartment of Physiology, Institute of Biomedicine and Turku Center for Disease Modeling, University of Turku, Turku, Finland.
Marjukka MyllärniemiTransplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland.
University of Helsinki · FIFinnish Institute of Occupational Health · FIUniversity of Turku · FIFimlab (Finland) · FIHelsinki University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is characterized by activation and injury of epithelial cells, the accumulation of connective tissue and changes in the inflammatory microenvironment. The bone morphogenetic protein (BMP) inhibitor protein gremlin-1 is associated with the progression of fibrosis both in human and mouse lung. We generated a transgenic mouse model expressing gremlin-1 in type II lung epithelial cells using the surfactant protein C (SPC) promoter and the Cre-LoxP system. Gremlin-1 protein expression was detected specifically in the lung after birth and did not result in any signs of respiratory insufficiency. Exposure to silicon dioxide resulted in reduced amounts of lymphocyte aggregates in transgenic lungs while no alteration in the fibrotic response was observed. Microarray gene expression profiling and analyses of bronchoalveolar lavage fluid cytokines indicated a reduced lymphocytic response and a downregulation of interferon-induced gene program. Consistent with reduced Th1 response, there was a downregulation of the mRNA and protein expression of the anti-fibrotic chemokine CXCL10, which has been linked to IPF. In human IPF patient samples we also established a strong negative correlation in the mRNA expression levels of gremlin-1 and CXCL10. Our results suggest that in addition to regulation of epithelial-mesenchymal crosstalk during tissue injury, gremlin-1 modulates inflammatory cell recruitment and anti-fibrotic chemokine production in the lung.

Indexed as

Up-RegulationAnimalsCell LineChemokine CXCL10CytokinesHumansIdiopathic Pulmonary FibrosisIntercellular Signaling Peptides and ProteinsInterferonsLungLymphocytesMiceMice, TransgenicSilicon DioxideChemokine CXCL10CytokinesGREM1 protein, humanGrem1 protein, mouseIntercellular Signaling Peptides and ProteinsInterferonsSilicon Dioxide

Identifiers

PMID27428020
PMCPMC4948891
OpenAlexW2506811152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.